RMD Open (Feb 2024)

Hyperactivation and altered selection of B cells in patients with paediatric Sjogren’s syndrome

  • Fabrizio De Benedetti,
  • Claudia Bracaglia,
  • Denise Pires Marafon,
  • Ivan Caiello,
  • Rebecca Nicolai,
  • Alessandra Boni,
  • Francesca Marinaro,
  • Luciapia Farina,
  • Rita Carsetti,
  • Emiliano Marasco

DOI
https://doi.org/10.1136/rmdopen-2023-003800
Journal volume & issue
Vol. 10, no. 1

Abstract

Read online

Objectives Paediatric Sjögren’s syndrome (pSS) is a rare chronic autoimmune disorder, characterised by inflammation of exocrine glands. B cell hyperactivation plays a central role in adult-onset Sjogren. This study was designed to analyse B cell and T cell phenotype, levels of BAFF, and selection of autoreactive B cells in patients with pSS.Methods A total of 17 patients diagnosed with pSS and 13 healthy donors (controls) comparable for age were enrolled in the study. B cell and T cell subsets and frequency of autoreactive B cells in peripheral blood were analysed by flow cytometry. Levels of BAFF were analysed by ELISA.Results The relative frequency of total B cells, transitional, naïve and switched memory B cells was similar between pSS patients and controls. In patients with pSS, we observed a reduction in the frequency of unswitched memory B cells, an increased frequency of atypical memory B cells and an expansion of PD1hi CXCR5− T peripheral helper cells. Levels of BAFF were higher in patients with pSS compared with controls and correlated with serum levels of total IgG and titres of anti-Ro antibodies. The frequency of autoreactive B cells in the transitional, unswitched memory and plasmablast compartment was significantly higher in pSS patients than in controls.Conclusions Our results point to a hyperactivation of B cells in pSS. Current therapies do not seem to affect B cell abnormalities, suggesting that novel therapies targeting specifically B cell hyperactivation need to be implemented for paediatric patients.